2-NBDG: Fluorescent Glucose Analog for Quantitative Cellular Uptake Assays

Executive Summary: 2-NBDG (2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose) is a water-soluble fluorescent glucose analog used to quantitatively measure cellular glucose uptake in live cells and animal models via flow cytometry and fluorescence microscopy [APExBIO]. It enters cells via glucose transporter proteins and is phosphorylated by hexokinase, leading to intracellular retention and strong fluorescence. 2-NBDG is widely used in diabetes, cancer, and neurological disease models for real-time glucose uptake analysis. Its uptake kinetics, solubility properties, and storage requirements are well characterized, supporting reproducible results. The product is distributed by APExBIO and has been validated in peer-reviewed studies and multiple internal resources [Hong et al., 2025].

Biological Rationale

Glucose uptake is a core indicator of cellular metabolism, essential for studying metabolic diseases (e.g., diabetes, cancer, epilepsy) and cellular physiology. Traditional radiolabeled tracers pose safety and disposal challenges. 2-NBDG offers a non-radioactive, high-sensitivity alternative with real-time detection capabilities. Its molecular structure mimics 2-deoxyglucose, allowing efficient transport via endogenous glucose transporter (GLUT) proteins. This makes it suitable for monitoring glucose transport dynamics in both normal and pathophysiological states [see also MoleculeProbes].

Mechanism of Action of 2-NBDG

2-NBDG enters cells through facilitative glucose transporters, primarily GLUT1 and GLUT4, depending on cell type. Once internalized, it is phosphorylated by hexokinase to 2-NBDG-6-phosphate, which cannot be further metabolized and is retained intracellularly. This leads to a stable fluorescent signal proportional to glucose uptake activity. The fluorescence maximum is typically 540 nm (excitation: 465 nm), compatible with standard flow cytometers and fluorescence microscopes. Quantitative uptake reflects both transporter activity and hexokinase function, key features for metabolic assays [Hong et al., 2025].

Evidence & Benchmarks

• 2-NBDG uptake in MCF-7 breast cancer cells occurs rapidly, reaching a plateau within 20–30 min at 10 μM, 37°C (see Table 2, Hong et al., 2025).
• 2-NBDG is insoluble in DMSO, but soluble in water (≥17.1 mg/mL with ultrasound) and ethanol (≥2.93 mg/mL with gentle warming); optimal preparation involves sonication and 37°C warming (APExBIO).
• In HepG2, L6, and astrocyte cultures, 2-NBDG at 10 μM for 10 min provides robust, cell-type-dependent uptake signals (see Supplementary Table S1, Hong et al., 2025).
• 2-NBDG enables localization of epileptic foci in Sprague–Dawley rats via in vivo fluorescence imaging (LimaprostResearch).
• Stock solutions are stable below -20°C for several months, but prepared solutions are not recommended for long-term storage (APExBIO).

This article extends prior work by providing updated protocols and clarifying differences in solubility and storage compared to AldosteroneLabs, which focused primarily on assay principles.

Applications, Limits & Misconceptions

2-NBDG is used extensively in research on glucose metabolism, including:

• Diabetes models (e.g., GDM, type 2 diabetes) for quantifying tissue or cellular glucose uptake (Hong et al., 2025).
• Cancer cell lines (e.g., HepG2, MCF-7) for metabolic profiling and drug screening (MoleculeProbesNet).
• Neurological research, including epilepsy and hyperglycemia models (LimaprostResearch).
• In vivo imaging of glucose metabolism in animal models.

Unlike radiolabels, 2-NBDG poses no radioactivity hazard and allows live-cell and in vivo imaging. It is compatible with standard laboratory equipment and can be multiplexed with other fluorescent probes.

Common Pitfalls or Misconceptions

• 2-NBDG is not metabolized beyond the initial phosphorylation step and does not report full glycolytic flux.
• It is insoluble in DMSO; use water or ethanol with ultrasound for stock preparation (APExBIO).
• Overextended incubation (>30 min) may lead to signal plateau or cytotoxicity in some sensitive cell lines.
• Signal intensity varies with transporter and hexokinase activity; interpretation requires appropriate controls.
• Long-term storage of working solutions leads to degradation; prepare fresh dilutions each time.

Workflow Integration & Parameters

2-NBDG (B6035) is supplied by APExBIO as a crystalline solid. Reconstitute at ≥17.1 mg/mL in water using ultrasound and 37°C warming for best solubility. Prepare working stocks fresh, store at -20°C, and avoid freeze-thaw cycles. For cell assays, incubate at 10 μM for 10 min at 37°C in glucose-free buffer to maximize specificity. Analyze uptake by flow cytometry (excitation: 465 nm, emission: 540 nm), microplate reader, or fluorescence microscopy. For in vivo use, dosing and imaging parameters should be empirically optimized per animal model. For additional protocol guidance, see CY5-NHS-Ester.com, which provides practical troubleshooting tips for 2-NBDG in cell-based workflows.

This article clarifies updated solubility and storage recommendations compared to MoleculeProbes.com, which primarily focused on detection sensitivity.

Conclusion & Outlook

2-NBDG provides a robust, quantitative, and safe means to measure cellular glucose uptake in a wide range of cell types and animal models. Its compatibility with standard fluorescence-based detection platforms enables broad adoption in metabolic research, drug screening, and disease model studies. As new disease models and imaging modalities emerge, 2-NBDG's role as a benchmark tracer is expected to expand. For detailed product specifications and ordering, visit the APExBIO 2-NBDG product page.